Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliet Barker

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell TransplantationAnat Stern, Yiqi Su, Yeon Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor programSergio Giralt, Brent Logan, Douglas Rizzo, et al.
Haematologica|January 28, 2017
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemiaClaudio Brunstein, Mei-Jie Zhang, Juliet Barker, et al.
Blood|August 27, 2009
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 unitsMichael R Verneris, Claudio G Brunstein, Juliet Barker, et al.
Transplantation and Cellular Therapy|October 3, 2023
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell TransplantationKarthik Nath, Kristen Peterson, Samantha Brown, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 5, 2019
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experienceAndrew Lin, Molly Maloy, Yiqi Su, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Transplantation and Cellular Therapy|June 17, 2026
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysisNeela Easton, Mia Andreoli, Herman van Besien, et al.
Leukemia & Lymphoma|February 10, 2022
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantationAndrew Lin, Samantha Brown, Molly Maloy, et al.
Transplantation and Cellular Therapy|October 8, 2023
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell TherapyMaria-Stefania Infante, David Nemirovsky, Sean Devlin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell TransplantationAnat Stern, Yiqi Su, Yeon Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor programSergio Giralt, Brent Logan, Douglas Rizzo, et al.
Haematologica|January 28, 2017
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemiaClaudio Brunstein, Mei-Jie Zhang, Juliet Barker, et al.
Blood|August 27, 2009
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 unitsMichael R Verneris, Claudio G Brunstein, Juliet Barker, et al.
Transplantation and Cellular Therapy|October 3, 2023
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell TransplantationKarthik Nath, Kristen Peterson, Samantha Brown, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 5, 2019
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experienceAndrew Lin, Molly Maloy, Yiqi Su, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Transplantation and Cellular Therapy|June 17, 2026
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysisNeela Easton, Mia Andreoli, Herman van Besien, et al.
Leukemia & Lymphoma|February 10, 2022
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantationAndrew Lin, Samantha Brown, Molly Maloy, et al.
Transplantation and Cellular Therapy|October 8, 2023
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell TherapyMaria-Stefania Infante, David Nemirovsky, Sean Devlin, et al.
Pageof 3